ABLIM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.007400E-01
Normal-vs-Stage2
6.574400E-01
Normal-vs-Stage3
7.935600E-01
Normal-vs-Stage4
2.852400E-01
Stage1-vs-Stage2
5.056400E-01
Stage1-vs-Stage3
3.545400E-01
Stage1-vs-Stage4
9.152600E-01
Stage2-vs-Stage3
4.103600E-01
Stage2-vs-Stage4
4.819000E-01
Stage3-vs-Stage4
2.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.969600E-01
Normal-vs-AfricanAmerican
4.046800E-01
Normal-vs-Asian
6.700000E-01
Caucasian-vs-AfricanAmerican
3.521000E-01
Caucasian-vs-Asian
7.893800E-01
AfricanAmerican-vs-Asian
3.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.751400E-01
Normal-vs-Female
7.537600E-01
Male-vs-Female
3.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.802600E-01
Normal-vs-Age(41-60Yrs)
4.573400E-01
Normal-vs-Age(61-80Yrs)
6.906200E-01
Normal-vs-Age(81-100Yrs)
7.831600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.600400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.759200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.156800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.408600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.941800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.400300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.388000E-01
Normal-vs-Daily Drinker
7.475400E-01
Normal-vs-Weekly Drinker
6.739200E-01
Normal-vs-Occasional Drinker
4.933400E-01
Normal-vs-Social Drinker
7.008800E-01
Non Drinker-vs-Daily Drinker
6.423800E-01
Non Drinker-vs-Weekly Drinker
3.046600E-01
Non Drinker-vs-Occasional Drinker
2.452600E-01
Non Drinker-vs-Social Drinker
7.097600E-01
Daily Drinker-vs-Weekly Drinker
2.054400E-01
Daily Drinker-vs-Occasional Drinker
6.111000E-01
Daily Drinker-vs-Social Drinker
9.250400E-01
Weekly Drinker-vs-Occasional Drinker
6.619800E-02
Weekly Drinker-vs-Social Drinker
2.004400E-01
Occasional Drinker-vs-Social Drinker
5.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.13140000035372E-07
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62436730732907E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.520400E-01
Grade 1-vs-Grade 3
6.217000E-01
Grade 1-vs-Grade 4
1.13140000035372E-07
Grade 2-vs-Grade 3
1.473020E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62436730732907E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.775200E-01
Normal-vs-NonDiabetic
6.800000E-01
Diabetic-vs-NonDiabetic
2.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.641600E-01
Normal-vs-NoPancreatitis
7.235200E-01
Pancreatitis-vs-NoPancreatitis
2.039000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.068000E-01
Normal-vs-N1
6.489600E-01
N0-vs-N1
5.301200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.805600E-01
Normal-vs-TP53-NonMutant
4.655000E-01
TP53-Mutant-vs-TP53-NonMutant
9.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
